Prostate Artery Embolization (PAE) offers a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH). Suitable for ...

Spruce Point Capital Management, LLC ("Spruce Point" or "we" or "us"), a New York-based investment management firm that focuses on forensic research and short-selling, today issued a detailed report ...

This study showed that BPH is a progressive condition that can lead to a worsening of symptoms, acute urinary retention and a need for surgery. Treatment with finasteride alone produced a 50% ...

Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product ...

The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

Dr Ademola Oyekan consultant radiation and clinical oncologist at the Lagos State University (LASUTH) speaks with Gboyega Alaka on Prostate cancer, why it is rampant among people of black race, plus ...

Procept’s recent launch of the Hydros system, which uses artificial intelligence, also faced skepticism from Spruce Point.

Hennion & Walsh Asset Management Inc. boosted its position in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 62.5% in the 4th quarter, according to the company in its most recent disclosure ...

Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Operating from his state-of-the-art clinic in Beverly Hills, Dr. Afshar offers a comprehensive range of urological services, including advanced treatments for prostate cancer, benign prostatic ...

Investments in biotechnology and oil and gas exploration entities.